We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Reox, a company spun out of Oxford University by four professors, is believed
to have struck a deal with the American biotech Amgen, providing it with £5
million for the exclusive rights to a scientific discovery involving possible
cancer and stroke treatments.
Indian subsidiaries of multinational drug companies are on the lookout for in-licensing
and marketing alliances with other foreign pharmaceutical companies for promoting
and distributing their products in the country.
Mediceo Holdings Co., Japan's largest drug wholesaler, said will acquire Paltac,
a household products wholesaler, for at least 59 billion yen ($548 million)
in stock and cash.
Inncardio, Inc., a company founded by Bioaccelerate
Holdings Inc. announced an agreement with Sigmoid Biotechnologies Ltd., based
in Dublin, Ireland, for the co-development and license of two novel formulations
of established drugs.
Amid an official tour of Africa, Nigeria's leaders have signed a
new agreement on the transfer of production technology for antiretroviral (ARV)
drugs with president da Silva of Brazil.
Throughout the Andean region, problems over patent protection, counterfeit
medicines and the enforcement of copyright laws have been key recent factors
slowing the market's overall performance.
Following the approval of India's new World Trade Organisation-compliant
intellectual property law, the country's drug industry is awaiting the Drugs
and Cosmetics (Amendment) Bill 2005, aimed at reducing counterfeiting in the
country.
Adventrx Pharmaceuticals, announced that it has received clearance from the
Medicines and Healthcare products Regulatory Agency (MHRA) to begin an international
Phase IIb randomized controlled clinical trial using CoFactor with 5-fluorouracil
(5-FU) in metastatic colorectal cancer in the United Kingdom.